Atrium Therapeutics, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
8.05
-0.15 (-1.83%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Atrium Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Initiates $15 | Buy | Initiates | $15 | +86.34% | Oct 22, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $25 | Buy | Maintains | $25 | +210.56% | Oct 15, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $25 | Buy | Maintains | $25 | +210.56% | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +210.56% | Aug 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +210.56% | May 15, 2026 |